Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06698705

The EEG Study Under Remimazolam Anesthesia in Children

Electroencephalogram Study in Children Under Remimazolam Anesthesia - a Prospective,Observational Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Second Affiliated Hospital of Wenzhou Medical University · Academic / Other
Sex
All
Age
1 Year – 12 Years
Healthy volunteers
Not accepted

Summary

The effect of Remimazolam on brain electrical activity. Previous studies have shown that in healthy male volunteers, EEG changes during Remimazolam infusion are characterized by an initial increase in the beta band and a later increase in the delta band. When monitoring the depth of anesthesia, the commonly used Bispectral Index in clinical practice was originally developed for propofol. Therefore, studies have shown that the correlation between the depth of sedation of benzodiazepines such as midazolam and Bispectral Index is weak. In contrast, the beta wave ratio is considered a more suitable EEG indicator for monitoring the sedative effect of Remimazolam. The above indicates that Remimazolam has a specific pattern of influence on EEG activity, especially in the regulation of anesthesia depth, with unique characteristics.

Detailed description

This study is a prospective, observational study.Children undergoing elective general anesthesia with Remimazolam will be divided into three groups (1-3 years old, 4-6 years old, 7-12 years old) based on their age range, with 20 cases in each group.Inform the family of the general research plan and obtain informed consent. Main outcome measure: Time frequency characteristics of electroencephalography (EEG) in children of different age groups under general anesthesia withRemimazolam (including anesthesia induction, maintenance, and recovery periods).

Conditions

Timeline

Start date
2024-11-22
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2024-11-21
Last updated
2025-02-06

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06698705. Inclusion in this directory is not an endorsement.